Company Description
Genesis Healthcare, Inc., together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States.
The company operates through three segments: Inpatient Services; Rehabilitation Therapy Services; and Other Services.
It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy.
In addition, the company offers other specialty medical services, such as physician, staffing, and other healthcare related services.
As of December 31, 2020, it provided inpatient services through a network of approximately 341 skilled nursing facilities and assisted/senior living communities in 24 states; and supplied rehabilitation and respiratory therapy to approximately 1,400 healthcare locations in 42 states, the District of Columbia and China.
The company was formerly known as FC-GEN Operations Investment, LLC and changed its name to Genesis HealthCare, Inc. in February 2015.
Genesis HealthCare, Inc. was founded in 2003 and is headquartered in Kennett Square, Pennsylvania.
| Country | United States |
| Founded | 2003 |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 44,000 |
| CEO | David Sheridan Harrington |
Contact Details
Address: 101 East State Street Kennett Square, Pennsylvania 19348 United States | |
| Phone | 610-444-6350 |
| Website | genesishcc.com |
Stock Details
| Ticker Symbol | GENN |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001351051 |
| CUSIP Number | 37185X106 |
| ISIN Number | US37185X1063 |
| SIC Code | 8051 |
Key Executives
| Name | Position |
|---|---|
| David Sheridan Harrington | Executive Chairman of the Board |
| Jonathan Kirschner | Chief Financial Officer |
| Stephen Scott Young | Senior Vice President of Finance, Chief Operating Officer, Chief Accounting Officer and Treasurer |
| Joseph C. Montgomery | Senior Vice President and Chief Information Officer |
| Lori Mayer | Vice President of Investor Relations, Brand Management and Marketing Communications |
| Julie Britton | Chief Clinical Officer |
| Michael T. Berg | Deputy General Counsel and Assistant Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 25, 2021 | 15-12B | Securities registration termination |
| Mar 16, 2021 | 10-K | Annual Report |
| Mar 15, 2021 | 25 | Filing |
| Mar 12, 2021 | EFFECT | Notice of Effectiveness |
| Mar 12, 2021 | 8-K | Current Report |
| Mar 8, 2021 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Mar 8, 2021 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Mar 8, 2021 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Mar 8, 2021 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Mar 8, 2021 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |